ORD 43914/2024

—·EP3666797: ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Case details: Status
—
Action
Procedural application
Category
Case Management Orders
Parties: Claimants
Amgen Inc.
Reps: Johannes Heselberger
Respondents
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Groupe S.A.
Sanofi Winthrop Industrie
Regeneron Pharmaceuticals Inc.
Reps: Niels Hölder
Division: Munich LD
Judges: Matthias Zigann · Presiding judge and judge-rapporteur
Tobias Pichlmaier · Legally qualified judge
Samuel Granata · Legally qualified judge
Xavier Dorland-Galliot · Technically qualified judge
Technology: Biotechnology
Language: —
First decided: Jul 29, 2024

Decisions

2024-07-29
Generic Order
The Munich Local Division issued a procedural order concerning a stay of infringement proceedings in the Amgen v Sanofi/Regeneron case relating to EP3666797, in light of parallel EPO opposition proceedings and a separate revocation action filed by the defendants at the UPC Central Division.
Legal issues:Stay of proceedings pending EPO oppositionParallel revocation action at UPC Central DivisionRelationship between infringement and revocation proceedings

Documents